[Durgical](https://durgical.com/en/) › [DurgiPedia](https://durgical.com/en/durgipedia/) › [Obstetrics and gynaecology](https://durgical.com/en/obstetrics-gynaecology/) › [Normal pregnancy and prenatal care](https://durgical.com/en/obstetrics-gynaecology/areas/pregnancy-care/) › Invasive prenatal tests: chorionic villus sampling, amniocentesis and cordocentesis

# Invasive prenatal tests: chorionic villus sampling, amniocentesis and cordocentesis

- Method or treatment

Screening only gives a chance. When a family needs a firm answer about the baby's chromosomes, blood or infection, a fine needle has to fetch fetal cells.

Updated Nov 20, 2026

**See it in 3D:** [Body of uterus](https://durgical.com/en/anatomy/body-of-uterus/)

## Key points

- CVS about 10 to 13 weeks ([placenta](https://durgical.com/en/histology/placenta/)); amniocentesis from 15 weeks (fluid); cordocentesis from about 18 weeks (fetal blood).
- Screening gives a chance; these tests give a diagnosis.
- CVS pitfall: placental mosaicism; confirm with amniocentesis.
- Cordocentesis carries the highest loss risk (about 1 to 3%) but can treat fetal anaemia by transfusion.
- Give anti-D to an RhD-negative woman without [antibodies](https://durgical.com/en/biochemistry/enzymes/immunoglobulins/) after any invasive test.

On this page

- The basics Key points
- What it is
- How to think about it
- How it works and how well
- Step by step
- The three invasive tests side by side
- Risks and who should not use it
- Next step / Follow-up
- Common traps
- Elsewhere in DurgiPedia

- Study Test yourself

- Connections Connections

## What it is

Invasive prenatal tests take a sample from inside the pregnancy under continuous ultrasound guidance. Chorionic villus sampling (CVS) takes placental tissue (chorionic villi) at about 10 to 13 weeks, through the abdomen or the [cervix](https://durgical.com/en/anatomy/cervix-of-uterus/). Amniocentesis takes amniotic fluid, which carries fetal cells shed from the skin, urine and lungs, from 15 weeks onwards. Cordocentesis, also called percutaneous umbilical blood sampling, puts a needle into the umbilical vein, usually near the placenta, from about 18 weeks; it is the only direct access to the fetal circulation, so the same needle can also give a transfusion. Unlike screening tests, which estimate risk, these tests give a diagnosis, at the price of a small risk of losing the pregnancy. They are offered with counselling, and the woman decides.

## How to think about it

Three needles, three targets, three windows: the placenta first, the fluid next, the baby's own blood last. The closer the needle gets to the fetus, the more direct the answer and the higher the risk. And what you sample decides what can go wrong: the placenta can carry a chromosome result the baby does not share, fluid cells must grow before some results, and a cord puncture can bleed or slow the fetal heart.

## How it works and how well

- Screening estimates a chance; CVS, amniocentesis and cordocentesis read fetal or placental cells directly and give a diagnosis. About 1 in 150 live births has a chromosomal abnormality.
- CVS: placental villi at about 10 to 13 weeks; karyotype results in about 7 to 10 days, weeks earlier than amniocentesis, so any decision can be made in the first trimester.
- Amniocentesis: from 15 weeks to term; in experienced hands the loss it adds is about one in a thousand in a singleton pregnancy. It can also treat: removing fluid in [polyhydramnios](https://durgical.com/en/conditions/amniotic-fluid-disorders/).
- Cordocentesis: fetal blood from about 18 weeks (safer around 20 to 28, when the cord is wider); results in one to three days; added loss about 1 to 3%, higher than the other two.
- Cordocentesis indications: suspected fetal anaemia (red cell alloimmunisation, [parvovirus B19](https://durgical.com/en/microbiology/parvovirus-b19/) with hydrops), with transfusion through the same needle; a rapid karyotype in two to three days; confirming mosaicism found on CVS or amniocentesis; some fetal infections and alloimmune thrombocytopenia.
- All three are sensitising events for an RhD-negative woman: the Colombian consensus on [Rh disease](https://durgical.com/en/conditions/rh-alloimmunisation-in-pregnancy/) lists CVS, amniocentesis and invasive fetal procedures such as cordocentesis among the events that call for [anti-D immunoglobulin](https://durgical.com/en/pharmacology/anti-d-immunoglobulin/).

## Step by step

- A screening result, a scan finding or the family history raises a question that only fetal cells or blood can answer.
- Counsel: what the test can and cannot show, the loss risk, the waiting time and what she might do with the answer; the choice is hers.
- Check gestational age, placental site and the cord on ultrasound, and her blood group and antibodies.
- Match the test to the weeks and the question: CVS at about 10 to 13 weeks, amniocentesis from 15 weeks, cordocentesis from about 18 weeks.
- Under continuous ultrasound guidance, a fine needle enters the placenta, the amniotic sac or the umbilical vein; experienced operators keep punctures few.
- Afterwards: check the fetal heart, give anti-D to an RhD-negative woman without antibodies, and explain what to report (leaking fluid, signs of infection).
- Read the result in context: a CVS mosaic or unclear result is confirmed on amniotic fluid or fetal blood before any decision.

## The three invasive tests side by side

| Feature | Chorionic villus sampling | Amniocentesis | Cordocentesis |
| --- | --- | --- | --- |
| What is sampled | Placental villi (chorion frondosum) | Amniotic fluid with shed fetal cells | Fetal blood from the umbilical vein |
| When | About 10 to 13 weeks | From 15 weeks to term | From about 18 weeks; safer around 20 to 28 |
| Route | Through the abdomen or the cervix | Through the abdomen | Through the abdomen into the cord, usually near the placenta |
| [Typical uses](https://durgical.com/en/conditions/rh-alloimmunisation-in-pregnancy/) | Early chromosome and gene tests | Chromosomes, genes, infection; removing fluid in polyhydramnios | Fetal anaemia and transfusion, rapid karyotype, confirming mosaicism, platelets, infection |
| Added loss in skilled hands | Similar to amniocentesis | About one in a thousand (singleton) | About 1 to 3% |
| Its own pitfall | Placental mosaicism (placenta and fetus differ); limb defects if done too early | Before 15 weeks: more loss and [clubfoot](https://durgical.com/en/conditions/clubfoot/); fluid leak in 1 to 2% | Cord bleeding, fetal bradycardia, carrying maternal infection to the fetus |

## Risks and who should not use it

- Amniocentesis before 15 weeks (early amniocentesis) carries more loss than CVS and a risk of clubfoot (talipes), thought to follow fluid loss; for an early answer, CVS is the test.
- After amniocentesis about 1 to 2% leak fluid; most leaks settle within days, and the loss attributable to the procedure is usually far smaller than the risk from the reason it was done.
- CVS done too early has been linked with limb reduction defects, which is why it waits until about 10 weeks. It is not done through the cervix when there is vaginal bleeding, a cervical abnormality or a severe infection.
- Confined placental mosaicism: a chromosome change present in the placenta but not in the fetus can give a false alarm (or false reassurance) after CVS; amniocentesis or fetal blood settles it.
- Cordocentesis risks: bleeding from the cord puncture, fetal bradycardia and, rarely, abruption with a needle through an anterior placenta; carrying maternal infection into the fetus is why testing the fetus for HIV this way is not advised. Complications rise with the number and duration of punctures, so it belongs in fetal medicine centres.

## Next step / Follow-up

- Give anti-D immunoglobulin to an RhD-negative woman without antibodies after any of the three tests, as the Colombian consensus sets; some countries omit it after CVS and amniocentesis because the evidence is limited.
- Refer to fetal medicine for suspected fetal anaemia: in the Colombian consensus, a woman with anti-D titres of 1:16 or more has [middle cerebral artery](https://durgical.com/en/anatomy/middle-cerebral-artery/) Doppler, and cordocentesis is done when anaemia is suspected, with transfusion if it is severe.
- Confirm a mosaic or unexpected CVS result with amniocentesis (or cordocentesis) before any decision is taken.
- Give results with [genetic counselling](https://durgical.com/en/biochemistry/topics/genetic-counselling-and-risk-assessment/) and support; if she considers ending the pregnancy, see the page on voluntary termination in Colombia.
- Ask her to report leaking fluid or signs of infection after the test; otherwise routine prenatal care continues.

## Common traps

- **A high-risk screening result means the baby is affected**: screening only estimates a chance; a diagnosis needs CVS, amniocentesis or cordocentesis.
- **CVS reads the baby's chromosomes**: it reads the placenta, and placental mosaicism can give a result the fetus does not share, so unexpected results are confirmed on fluid or blood.
- **Earlier is always better, so do the amniocentesis at 12 weeks**: before 15 weeks amniocentesis carries more loss than CVS and a clubfoot risk; the early test is CVS.
- **Anti-D is only needed after the birth**: CVS, amniocentesis and cordocentesis can all let fetal blood into the mother, so an RhD-negative woman without antibodies is protected after each one.
- **Cordocentesis is just a riskier amniocentesis**: it is the only route into the fetal circulation, so the same puncture that confirms severe anaemia can treat it with a transfusion.

## Test yourself

Think of the answer, then tap the question to see it.

## A woman wants a diagnostic test at 11 weeks after a high-risk combined screen. Which test fits, and why not amniocentesis?

CVS: it is done at about 10 to 13 weeks and gives results within the first trimester. Amniocentesis before 15 weeks carries more loss than CVS and a risk of clubfoot.

## CVS shows trisomy in some cells only. What is the next step and why?

Confirm with amniocentesis (or fetal blood): the change may be confined to the placenta, so the fetus may be normal.

## Why can cordocentesis be therapeutic when the other two tests cannot?

It is the only direct access to the fetal circulation: if the blood shows severe anaemia, the needle stays in the umbilical vein and red cells are transfused.

## An RhD-negative woman without antibodies has an amniocentesis at 16 weeks. What should she receive and why?

Anti-D immunoglobulin: the needle can let fetal red cells into her circulation, and the Colombian consensus counts amniocentesis as a sensitising event.

[Add to my cards (4)](https://durgical.app/estudiar/?add=/en/obstetrics-gynaecology/invasive-prenatal-tests-chorionic-villus-sampling-amniocentesis-and-cordocentesi/)

## Elsewhere in DurgiPedia

- [Prenatal diagnosis: ultrasound, serum screening, cell-free DNA, CVS, amniocentesis](https://durgical.com/en/embryology/prenatal-diagnosis-ultrasound-serum-screening-cell-free-dna-cvs-amniocentesis/)
- [Fetal therapy: intrauterine transfusion, fetal medicines and surgery](https://durgical.com/en/embryology/fetal-therapy-intrauterine-transfusion-fetal-medicines-and-surgery/)
- [First-trimester ultrasound: intrauterine pregnancy, dating and ectopic](https://durgical.com/en/radiology/first-trimester-ultrasound-intrauterine-pregnancy-dating-and-ectopic/)
- [Rh incompatibility](https://durgical.com/en/physiology/rh-incompatibility/)

## Connections

## See it in 3D 1

The structures of Durgical's 3D anatomy where it is found.

- [Body of uterus](https://durgical.com/en/anatomy/body-of-uterus/)

## Related 6

- [Screening for chromosomal anomalies: combined test, cell-free DNA, diagnostic tests](https://durgical.com/en/obstetrics-gynaecology/screening-for-chromosomal-anomalies-combined-test-cell-free-dna-diagnostic-tests/)
- [Rh and red cell alloimmunisation: prevention and follow-up](https://durgical.com/en/obstetrics-gynaecology/rh-and-red-cell-alloimmunisation-prevention-and-follow-up/)
- [Common fetal anomalies on ultrasound and what happens next](https://durgical.com/en/obstetrics-gynaecology/common-fetal-anomalies-on-ultrasound-and-what-happens-next/)
- [Antenatal fetal surveillance: movements, non-stress test, biophysical profile, Doppler](https://durgical.com/en/obstetrics-gynaecology/antenatal-fetal-surveillance-movements-non-stress-test-biophysical-profile-doppl/)
- [Infections that harm the fetus: syphilis, HIV, toxoplasma, CMV, rubella, Zika, dengue, malaria, Chagas, hepatitis B](https://durgical.com/en/obstetrics-gynaecology/infections-that-harm-the-fetus-syphilis-hiv-toxoplasma-cmv-rubella-zika-dengue-m/)
- [Voluntary termination of pregnancy in Colombia: the law and the doctor's role](https://durgical.com/en/obstetrics-gynaecology/voluntary-termination-of-pregnancy-in-colombia-the-law-and-the-doctor-s-role/)

## Related conditions 4

- [Rh alloimmunisation in pregnancy](https://durgical.com/en/conditions/rh-alloimmunisation-in-pregnancy/)
- [Down syndrome (trisomy 21)](https://durgical.com/en/conditions/down-syndrome/)
- [Trisomy 18 (Edwards) and trisomy 13 (Patau)](https://durgical.com/en/conditions/trisomy-18-and-trisomy-13/)
- [Amniotic fluid disorders (polyhydramnios, oligohydramnios)](https://durgical.com/en/conditions/amniotic-fluid-disorders/)

## In Pharmacology 1

- [Anti-D immunoglobulin (Rho(D))](https://durgical.com/en/pharmacology/anti-d-immunoglobulin/)

[← All of obstetrics and gynaecology](https://durgical.com/en/obstetrics-gynaecology/)

Educational content; it does not replace assessment by a doctor or your institution's protocols, and it contains no doses. For heavy bleeding, a severe headache or blurred vision, a seizure, fever, strong abdominal pain or fewer baby movements, go to an emergency department at once.

Sources: [Amniocentesis](https://www.ncbi.nlm.nih.gov/books/NBK559247/) (StatPearls Publishing (NCBI Bookshelf), 2023); [Chorionic Villus Sampling](https://www.ncbi.nlm.nih.gov/books/NBK563301/) (StatPearls Publishing (NCBI Bookshelf), 2025); [A Review of Cordocentesis: Percutaneous Umbilical Cord Blood Sampling](https://pmc.ncbi.nlm.nih.gov/articles/PMC8369974/) (Cureus (Peddi NC et al.), 2021); [Consenso colombiano de diagnóstico, prevención y manejo de la enfermedad Rh](https://pmc.ncbi.nlm.nih.gov/articles/PMC11457932/) (Revista Colombiana de Obstetricia y Ginecología (FECOLSOG), 2024); [FIGO/ICM guidelines for preventing Rhesus disease: A call to action](https://pmc.ncbi.nlm.nih.gov/articles/PMC7898700/) (International Journal of Gynecology & Obstetrics, 2021).

## **Spotted a mistake?** We are always improving for the community. Tell us what is wrong and our team will review it. Report a mistake

Representative model, for educational purposes only.

---
Source: https://durgical.com/en/obstetrics-gynaecology/invasive-prenatal-tests-chorionic-villus-sampling-amniocentesis-and-cordocentesi/
License: CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). Cite as: DurgiPedia (durgical.com), https://durgical.com/en/obstetrics-gynaecology/invasive-prenatal-tests-chorionic-villus-sampling-amniocentesis-and-cordocentesi/
